BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 38829126)

  • 1. Human cytomegalovirus UL23 exploits PD-L1 inhibitory signaling pathway to evade T cell-mediated cytotoxicity.
    Yuan Q; Fan Z; Huang W; Huo X; Yang X; Ran Y; Chen J; Li H
    mBio; 2024 Jun; ():e0119124. PubMed ID: 38829126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human Cytomegalovirus UL23 Antagonizes the Antiviral Effect of Interferon-γ by Restraining the Expression of Specific IFN-Stimulated Genes.
    Wang H; Peng W; Wang J; Zhang C; Zhao W; Ran Y; Yang X; Chen J; Li H
    Viruses; 2023 Apr; 15(4):. PubMed ID: 37112994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human cytomegalovirus UL23 inhibits transcription of interferon-γ stimulated genes and blocks antiviral interferon-γ responses by interacting with human N-myc interactor protein.
    Feng L; Sheng J; Vu GP; Liu Y; Foo C; Wu S; Trang P; Paliza-Carre M; Ran Y; Yang X; Sun X; Deng Z; Zhou T; Lu S; Li H; Liu F
    PLoS Pathog; 2018 Jan; 14(1):e1006867. PubMed ID: 29377960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human Cytomegalovirus UL23 Attenuates Signal Transducer and Activator of Transcription 1 Phosphorylation and Type I Interferon Response.
    Feng L; Li W; Wu X; Li X; Yang X; Ran Y; Wu J; Li H
    Front Microbiol; 2021; 12():692515. PubMed ID: 34305856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human Cytomegalovirus Tegument Protein pp65 (pUL83) Dampens Type I Interferon Production by Inactivating the DNA Sensor cGAS without Affecting STING.
    Biolatti M; Dell'Oste V; Pautasso S; Gugliesi F; von Einem J; Krapp C; Jakobsen MR; Borgogna C; Gariglio M; De Andrea M; Landolfo S
    J Virol; 2018 Mar; 92(6):. PubMed ID: 29263269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human Cytomegalovirus (HCMV)-Specific CD4
    Jackson SE; Sedikides GX; Mason GM; Okecha G; Wills MR
    J Virol; 2017 Mar; 91(6):. PubMed ID: 28053099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diverse specificities, phenotypes, and antiviral activities of cytomegalovirus-specific CD8+ T cells.
    Jackson SE; Mason GM; Okecha G; Sissons JG; Wills MR
    J Virol; 2014 Sep; 88(18):10894-908. PubMed ID: 25008941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic Variability of Human Cytomegalovirus Clinical Isolates Correlates With Altered Expression of Natural Killer Cell-Activating Ligands and IFN-γ.
    Galitska G; Coscia A; Forni D; Steinbrueck L; De Meo S; Biolatti M; De Andrea M; Cagliani R; Leone A; Bertino E; Schulz T; Santoni A; Landolfo S; Sironi M; Cerboni C; Dell'Oste V
    Front Immunol; 2021; 12():532484. PubMed ID: 33897679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strategy of Human Cytomegalovirus To Escape Interferon Beta-Induced APOBEC3G Editing Activity.
    Pautasso S; Galitska G; Dell'Oste V; Biolatti M; Cagliani R; Forni D; De Andrea M; Gariglio M; Sironi M; Landolfo S
    J Virol; 2018 Oct; 92(19):. PubMed ID: 30045985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human Cytomegalovirus miR-US33as-5p Targets IFNAR1 to Achieve Immune Evasion During Both Lytic and Latent Infection.
    Zhang Q; Song X; Ma P; Lv L; Zhang Y; Deng J; Zhang Y
    Front Immunol; 2021; 12():628364. PubMed ID: 33746965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and Functional Characterization of a Novel Fc Gamma-Binding Glycoprotein in Rhesus Cytomegalovirus.
    Kolb P; Sijmons S; McArdle MR; Taher H; Womack J; Hughes C; Ventura A; Jarvis MA; Stahl-Hennig C; Hansen S; Picker LJ; Malouli D; Hengel H; Früh K
    J Virol; 2019 Feb; 93(4):. PubMed ID: 30487278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural killer cells can inhibit the transmission of human cytomegalovirus in cell culture by using mechanisms from innate and adaptive immune responses.
    Wu Z; Sinzger C; Reichel JJ; Just M; Mertens T
    J Virol; 2015 Mar; 89(5):2906-17. PubMed ID: 25540381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis B virus-triggered PTEN/β-catenin/c-Myc signaling enhances PD-L1 expression to promote immune evasion.
    Sun Y; Yu M; Qu M; Ma Y; Zheng D; Yue Y; Guo S; Tang L; Li G; Zheng W; Wang M; Guo D; Li C
    Am J Physiol Gastrointest Liver Physiol; 2020 Jan; 318(1):G162-G173. PubMed ID: 31604033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human Cytomegalovirus Protein UL94 Targets MITA to Evade the Antiviral Immune Response.
    Zou HM; Huang ZF; Yang Y; Luo WW; Wang SY; Luo MH; Fu YZ; Wang YY
    J Virol; 2020 Jun; 94(12):. PubMed ID: 32238587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human Cytomegalovirus Immediate Early 86-kDa Protein Blocks Transcription and Induces Degradation of the Immature Interleukin-1β Protein during Virion-Mediated Activation of the AIM2 Inflammasome.
    Botto S; Abraham J; Mizuno N; Pryke K; Gall B; Landais I; Streblow DN; Fruh KJ; DeFilippis VR
    mBio; 2019 Feb; 10(1):. PubMed ID: 30755509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apoptosis induced by human cytomegalovirus infection can be enhanced by cytokines to limit the spread of virus.
    Chaudhuri AR; St Jeor S; Maciejewski JP
    Exp Hematol; 1999 Jul; 27(7):1194-203. PubMed ID: 10390195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human Cytomegalovirus DNA Polymerase Subunit UL44 Antagonizes Antiviral Immune Responses by Suppressing IRF3- and NF-κB-Mediated Transcription.
    Fu YZ; Su S; Zou HM; Guo Y; Wang SY; Li S; Luo MH; Wang YY
    J Virol; 2019 Jun; 93(11):. PubMed ID: 30867312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human Macrophages Escape Inhibition of Major Histocompatibility Complex-Dependent Antigen Presentation by Cytomegalovirus and Drive Proliferation and Activation of Memory CD4
    Frascaroli G; Lecher C; Varani S; Setz C; van der Merwe J; Brune W; Mertens T
    Front Immunol; 2018; 9():1129. PubMed ID: 29887865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Human Cytomegalovirus Protein UL148A Downregulates the NK Cell-Activating Ligand MICA To Avoid NK Cell Attack.
    Dassa L; Seidel E; Oiknine-Djian E; Yamin R; Wolf DG; Le-Trilling VTK; Mandelboim O
    J Virol; 2018 Sep; 92(17):. PubMed ID: 29950412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined Immune Checkpoint Blockade Enhances Antiviral Immunity against Bovine Leukemia Virus.
    Nakamura H; Konnai S; Okagawa T; Maekawa N; Sajiki Y; Watari K; Kamitani K; Saito M; Kato Y; Suzuki Y; Murata S; Ohashi K
    J Virol; 2023 Jan; 97(1):e0143022. PubMed ID: 36598199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.